| INTRODUCTION
Ginkgo biloba has been used for more than 3,500 years to improve cognitive functions. [1, 2] Although its short-term clinical benefit remains controversial, [3] [4] [5] [6] [7] [8] [9] a recent longterm population-based study indicated that G. biloba helped non-demented people maintain cognitive functions. [10] The clinical benefit of G. biloba is in agreement with its pharmacological effects. Ginkgo biloba protects neurons from free radical damages [11] and Aβ-mediated neurotoxicity [12] [13] [14] ; it also promotes neurogenesis [15] and improves neurotransmission. [16] [17] [18] These pharmacological effects are attributed to two major groups of chemical constituents, namely flavonoids and terpene trilactones. Flavonoids in G. biloba, such as quercetin, are potent antioxidants, [19] which may contribute to the neuroprotective effect. However, flavonoids are not unique to G. biloba; they exist in many other plants.
The chemical constituents unique to G. biloba are terpene trilactones, such as ginkgolides. Ginkgolides are known as antagonists of the platelet-activating factor (PAF) receptor. [2] In addition, they exhibit various pharmacological activities, including neuroprotective and anxiolytic effects. [20] [21] [22] [23] [24] Although ginkgolides exhibit diverse effects on neurons, their macromolecular target in brain is unknown. This is an important problem because without the knowledge of binding target, it would not be possible to understand the mechanism by which ginkgolides modulate neuronal and cognitive functions. Here, we report that benzophenone derivatives of ginkgolides selectively photocrosslink α-tubulin in brain. In addition, ginkgolides modulate MT biology in a manner that is distinctly different from taxol, which is a prototypical MT-binding agent targeting β-tubulin. These findings provide new clues to understand the neurobiological effects of ginkgolides and G. biloba.
| METHODS AND MATERIALS

| Photoaffinity labeling of hippocampus tissues
Ginkgolide photoprobes 1-3 were synthesized previously. [25] Hippocampus tissues were obtained from mouse and bovine cadavers. Tissues were homogenized in M-PER Mammalian Protein Extraction Reagent (Pierce) (tissue:buffer = 1:20) using a Dounce tissue homogenizer on ice. Homogenates were centrifuged at 10,000 g for 5 min. The supernatant was transferred to a new tube, and the concentration of total protein was adjusted to 4 μg/μl. Photolabeling was carried out using a reported protocol [26] with a minor modification. Briefly, 
| Western blot of photolabeled hippocampus homogenate
The photolabeled mouse hippocampus homogenates were mixed with Laemmli Sample Buffer (BioRad) 5%(v/v) containing 2-mercaptoethanol, denatured at 80°C for 5 min, and separated on SDS-PAGE (10% Tris-HCl gel, 200 V, 1 h) in 1× Tris-Glycine-SDS buffer (BioRad). Gel was blotted onto PVDF membrane (200 mA, 2 hr) in a cold transfer buffer (20% methanol in 1× Tris-Glycine buffer). Blotted membrane was blocked with 5% non-fat milk in 50 ml TBS-T for 1 hr. Blocked membrane was rinsed with TBS-T (5 min × 3), treated with avidin-horseradish peroxidase (HRP) (BioRad, 1:3,000 dilution in 5% non-fat milk in TBS-T, 50 ml for 30 min), and washed with TBS-T (20 min × 4). The washed membrane was treated with the Immobilon ™ Western chemiluminescent HRP substrate for 5 min. Bands were observed with the BioRad ChemiDoc gel documentation system.
| Affinity purification of photolabeled proteins and SDS-PAGE
Affinity purification of photochemically biotinylated proteins was carried out with ImmunoPure immobilized tetrameric avidin resin (Pierce). The photolabeled bovine hippocampus homogenates were mixed with the resin and incubated overnight at 4°C. The supernatant was removed and the gel was washed with 1× TBS-T (30 min × 5). The washed resin was mixed with Laemmli Sample Buffer (BioRad) containing 5%(v/v) 2-mercaptoethanol, denatured at 80°C for 5 min, and subjected to SDS-PAGE (10% Tris-HCl gel, 200 V, 1 hr) in 1× Tris-Glycine-SDS buffer (BioRad). Coomassie Blue stain was used to visualize the 50 kDa band, which was excised and subjected to the MS analyses.
| Mass spectrometry
Proteins in the gel slice were reduced, alkylated, and subjected to in-gel proteolytic digestion with trypsin. Resulting peptides were extracted two times with 40% acetonitrile and 2% formic acid mixture, and dried down. Peptides were resuspended in sample loading buffer that contained 5% acetonitrile and 2% formic acid. Peptides were separated and analyzed using Ultimate 3,000 nano-HPLC system coupled to the LTQ-Orbitrap XL mass spectrometer from Thermo Scientific. Following the loading on the C 18 trap column (5 μm ID beads, Thermo Scientific) at the flow rate of 3 μl/min, peptide separation was achieved during a 50-min gradient (buffer A was 0.1% formic acid in water, buffer B was 0.1% formic acid in acetonitrile) using a C 18 analytical column (3 μm ID beads, Nikkyo Technologies) at the flow rate of 0.3 μl/min. Mass spectra were recorded in a 300-1,800 m/z mass range, with 60,000 resolution for precursor scan and 30,000 resolution for fragment ions. Data were recorded in profile mode. Ten precursors from each scan were selected for fragmentation. Dynamic exclusion was used to resolve the less intense components of the sample with the following parameters: exclusion list size 500, duration 60 s, exclusion by mass with both high and low exclusion mass widths of 5 ppm. The normalized collision energy in the ion trap was 35. Data were extracted and searched against Bovine Uniprot database using Proteome Discoverer 1.4 (Thermo Scientific) and Mascot 2.4 (Matrix Science). Potential common fetal bovine serum and human contaminants were included in the search (see Supplementary Table) and labeled CON in the accession number. Identified peptides were filtered using 1% false discovery rate on Percolator. [27] In the table, proteins were sorted according to their relative abundance, which is represented by the peak area. The protein area was calculated as an average of the areas of the three most abundant peptides for that protein.
| Tubulin polymerization assay
The effect of ginkgolide A on tubulin polymerization was examined with a commercial tubulin polymerization assay kit (BK006P) from Cytoskeleton (Denver, CO, USA). This assay is based on the fact that light scattering by MTs is proportional to the concentration of MTs. The assay followed the protocol provided by the manufacturer. Duplicate experiments were carried out, and representative results are shown in Figure 2a ; the two sets of experiments were nearly identical.
| Cell proliferation assay
Human ARPE-19 cells (a human retinal pigment epithelial cell line) (ATCC) were grown in Dulbecco's modified Eagle's medium/nutrient mixture F12 without glucose (DMEM/F12, US Biological, MA, USA) with 10% fetal bovine serum (Fetal Bovine Serum, Standard Quality, PAA Laboratories, Inc., Etobicoke, Ontario, Canada), 5.5 mM glucose, 5 mM HEPES, 1 mM sodium pyruvate, and 1% l-glutamine-penicillin-streptomycin (Sigma, St. Louis, MO, USA) at 37°C and 5% CO 2 . Cells were plated into 96-well plates at approximately 50% confluency. Cells were treated with DMSO (vehicle control) and samples (5, 100, and 500 nM of taxol and 5, 25, 100, 500 nM, 1, 10, 25, and 50 μM of ginkgolide A). Three and five days after treatment, resazurin reduction rates were measured. Resazurin (7-hydroxy-3H-phenoxazin-3-on e-10-oxide) was prepared as a stock solution of 75 μg/ml in calcium-and magnesium-free PBS and added to wells to give a final concentration of 10 μg/ml. Resorufin fluorescence was measured over 2 hr at 10-min intervals at 37°C using SpectraMax Paradigm Multi-Mode Microplate Detection Platform (Molecular Devices LLC, Sunnyvale, CA, USA) by exciting at 530 nm and recording emission at 590 nm. The rate of resazurin reduced was calculated by fitting the rate of resorufin appearance to a line, the slopes of which were defined as resazurin reduction rates. For determining p values, we compared the resazurin reduction rates for control with treated groups using two-tailed, unpaired t tests (*p < .05).
| Effects of ginkgolide A on LPA-induced MT detyrosination and MTOC reorientation in motile fibroblasts
Serum-starved NIH3T3 fibroblasts were treated with 10 μM LPA and/or ginkgolide A (20 or 50 μM) for 2 hr and then fixed in methanol at −20°C. Fixed cells were immunofluorescently stained for detyrosinated (Glu) α-tubulin, tyrosinated (Tyr) α-tubulin (a marker of dynamic MTs), pericentrin [a marker of the centrosome/microtubule-organizing centers (MTOCs)], and DAPI to stain nuclei. Alternatively, treated cells were fixed in 4% paraformaldehyde and stained with fluorescently labeled phalloidin to visualize actin filaments. The extent of detyrosinated MT formation was scored by determining the percentage of cells with detyrosinated MTs (ΔY-MTs): cells were scored positive if >10 MTs were brightly stained by the Glu antibody. In the case of MTOC reorientation, cells were scored positive if the centrosome was in the pie-shaped sector facing the leading edge as described previously. [28] Scoring was performed blinded, and results were quantified and expressed as the means ± standard deviation from three independent experiments (n > 100 per experiment). The p values were derived from unpaired, two-tailed Student's t-test (n.s. p > .05; ***p < .0005; **p < .005).
| RESULTS AND DISCUSSION
In order to identify the target of ginkgolides in brain, we employed their derivatives with benzophenone and biotin that can photochemically biotinylate the binding target ( Figure 1a) . [25] Homogenates of mouse hippocampus were photolabeled with two photoactive analogs of ginkgolide A, 1 and 2. Biotinylated proteins were visualized by Western blot, which revealed a distinct band near 50 kDa (Figure 1b, lanes  3 and 5) . The fact that both 1 and 2 gave the same 50 kDa band, which was not observed in the background (lane 2), suggested that this 50 kDa band was the binding target of ginkgolide A. The intensity of this band diminished in the presence of free ginkgolide A (10× higher concentration than 2)a (lane 6), indicating that the 50 kDa protein(s) recognized the ginkgolide framework.
To identify the protein(s) in the 50 kDa band, photolabeling was repeated in a large scale using bovine hippocampus homogenates (Supplementary Scheme S1). The homogenate was photolabeled by 2. Photochemically biotinylated proteins were purified by streptavidin-affinity resin. Affinity-purified sample was separated by SDS-PAGE and visualized by Coomassie Blue stain. The 50 kDa band was excised and subjected to mass spectrometry (MS) for protein identification. Table 1 summarizes the most abundant proteins identified in this study (see Supplementary Table for the complete list). It turned out that the top proteins were all α-tubulin isotypes: the "uncharacterized" proteins on the table were all classified as α-tubulin proteins (by sequence). This is not non-specific photolabeling of abundant proteins in brain because the photolabeling occurred selectively with α-tubulin over β-tubulin, which is equally abundant in brain homogenate.
To verify the finding, photolabeling was repeated with a purified bovine MT protein (purity >99%), in which the polymerized form of MT was stabilized by taxol. The MT protein was subjected to photolabeling with 2 and 3, which were photoprobes of ginkgolides A and B, respectively (Figure 1a) . Both 2 and 3 photolabeled MT efficiently as demonstrated by dot blot analyses (Figure 1c, d) . Collectively, our photoaffinity-labeling studies indicated that ginkgolides selectively target α-tubulin in MTs.
The identification of α-tubulin raised a possibility that ginkgolides might modulate MT biology differently than typical MT-binding agents targeting β-tubulin, [29] such as vinblastine and taxol. As such, we conducted preliminary biochemical and biological studies on ginkgolide A. To examine the effect of ginkgolides on MT assembly, ginkgolide A was subjected to a tubulin polymerization assay, [30] in which the polymerization was monitored by the increase in optical density at 340 nm. While 10 μM taxol ("Taxol10" in Figure 2a ; the positive control) rapidly polymerized the αβ-tubulin dimer into MTs, ginkgolide A at 10 and 100 μM | KAWAMURA et Al.
("GA10" and "GA100") gave the results that were identical to the profile of DMSO vehicle control (Figure 2a) . The result indicated that ginkgolide A had no effect on the assembly of tubulin. Furthermore, ginkgolide A at 50 μM did not affect the proliferation of ARPE-19 cells (a human retinal pigment epithelial cell line), whereas 5 nM taxol significantly inhibited (Figure 2b ). Taken together, these results suggested that although ginkgolide A targets α-tubulin, it has no effect on the cytoskeletal functions of MT. Although ginkgolide A did not affect cytoskeletal functions of MT, there remained a possibility that it could still modulate the biological processes involving α-tubulin. α-Tubulin has recently emerged as hotspots for posttranslational modifications (PTMs), such as the detyrosination-tyrosination cycle (Figure 3a) . [31] The PTMs of α-tubulin are pronounced in polarized cells, including neurons, and believed to control cell polarity and polarized cargo transport. [32] [33] [34] [35] [36] As such, we wondered if ginkgolides might modulate α-tubulin PTMs.
To examine this possibility, we turned to a well-established model of α-tubulin detyrosination in motile NIH3T3 fibroblasts. [37] In this model, a monolayer of serum-starved fibroblasts is wounded, which is followed by wound closure by migrating fibroblasts in the presence of lysophosphatidic acid (LPA), a serum mitogen (Supplementary Figure S1) . Wounding in the presence of LPA induced detyrosinated MTs (ΔY-MTs) in the fibroblasts along the wound (the wound is the dark area in the image) ( Figure 3b Figure S3) .
It is noted that the observed effect of ginkgolide A is not the consequence of non-specific disruption of cytoskeletal structures. When tyrosinated MT (Tyr) and filamentous actin were visualized in fibroblasts, ginkgolide A had no effect on the distribution of MTs or actin (Supplementary Figures S3  and S4 ). Taken together, ginkgolide A selectively inhibited MT detyrosination and MTOC reorientation without affecting the overall cytoskeletal structures.
Although further studies are needed to clearly define the effects of ginkgolides on α-tubulin biology, the current study suggests that ginkgolides constitute a new class of MT-modulating agents. The photoaffinity-labeling study suggests that ginkgolides selectively bind to α-tubulin in bovine hippocampus homogenates. Although photoaffinity labeling has its own limitations such as off-target interactions, the current finding of α-tubulin does not appear to be nonspecific photocrosslinking of abundant proteins for the following two reasons: (i) the excess amount of free ginkgolide A attenuated the photolabeling of α-tubulin (10× higher concentration than 2) and (ii) photolabeling selectively occurred on α-tubulin over equally abundant β-tubulin. Unlike typical MT-binding agents targeting β-tubulin, [29, 38] ginkgolide A does not affect MT polymerization or cell proliferation. Instead, it inhibits α-tubulin detyrosination and reorientation of MTOCs. As noted earlier, PTMs of α-tubulin play important roles in cell polarization and polarized cargo transport. [32] [33] [34] [35] [36] Reorientation of MTOCs is the hallmark of various biological processes, including cell division, cell polarization, axonal specification in neurons, and interaction between T cells and antigen-presenting cells. [39] [40] [41] [42] As such, the current findings warrant further studies to define the scope of this newly discovered biological effect of ginkgolides.
The current study also raises several new questions regarding ginkgolides' mechanism of action in vivo. The first question is whether the brain is the only organ that mediates their beneficial effects. The expression of α-tubulin is not limited to the central nervous system (CNS), although it is abundant in neuronal cells. In addition, a previous biodistribution study of 18 F-labeled ginkgolide B (GB) indicated that GB, when injected in rats, rapidly accumulated in the liver and the intestine [43] ; on the other hand, GB exhibited low blood-brain barrier permeability. The accumulation of ginkgolides in the intestine might be relevant to their biological effects because recent studies revealed the emerging roles of enteric nervous system (ENS) in neurological disorders including Alzheimer's disease. [44] The second question is whether α-tubulin is really the only major target of ginkgolides in vivo. This question stems from the observation that ginkgolides exists in two forms in vivo: namely (i) the original form with its lactone rings closed and (ii) a second form with one of the lactone rings open ("the open form"). [43] Further studies are needed to determine whether the open form also binds to α-tubulin or it has some other target.
| CONCLUSION
In conclusion, the current work suggests that ginkgolides are a new class of MT-modulating agents with distinct effects on α-tubulin biology. The finding heralds a new chapter of the research on ginkgolides whose biological potential is yet to be discovered.
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